董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Weiguang Yang | 男 | President, Chief Executive Officer and Chairman of the Board | 42 | 6.67万美元 | 54.98 | 2025-04-25 |
| Kevin Dean Vassily | 男 | Independent director | 58 | 未披露 | 1.54 | 2025-04-25 |
| 李丹 | 女 | Independent director | 48 | 未披露 | 1.54 | 2025-04-25 |
| John C. General | 男 | Independent director | 62 | 未披露 | 1.54 | 2025-04-25 |
| 徐珮 | 女 | Chief Financial Officer, Secretary and Director | 43 | 4.58万美元 | 2.93 | 2025-04-25 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Weiguang Yang | 男 | President, Chief Executive Officer and Chairman of the Board | 42 | 6.67万美元 | 54.98 | 2025-04-25 |
| 陈学军 | 男 | Chief Medical Officer | 45 | 6.34万美元 | 5.91 | 2025-04-25 |
| 田宝乾 | 男 | Chief Sales Officer | 40 | 8.34万美元 | 1.71 | 2025-04-25 |
| 吴爽 | 女 | Chief Operating Officer | 41 | 3.17万美元 | 5.59 | 2025-04-25 |
| 徐珮 | 女 | Chief Financial Officer, Secretary and Director | 43 | 4.58万美元 | 2.93 | 2025-04-25 |
董事简历
中英对照 | 中文 | 英文- Weiguang Yang
-
Weiguang Yang为Tradeup Acquisition Corp.的联席首席执行官兼董事。Yang先生目前担任Zhongchao Inc.总裁、董事长兼首席执行官，Zhongchao Inc.是一家在纳斯达克上市的公司（Nasdaq：ZCMD），他于2012年创立了Zhongchao Inc.。2013年6月至2016年6月，Yang先生担任全球医学教育联盟的首位中国董事会成员，该联盟是一个致力于推动世界各地医学教育创新的非营利组织。从2005年10月至2012年7月，Yang先生在医学继续教育公司Medwork担任总经理。Yang先生于2005年获得赣南医科大学临床医学科学（创伤外科）学士学位。2006年至2008年，Yang先生还参加了中国首都医科大学社会医学与健康管理硕士课程的继续教育。2010年至2012年，Yang先生在清华大学攻读整合营销传播硕士课程。
Weiguang Yang,is the founder of Zhongchao Inc. and Zhongchao Shanghai. He has served as general manager Zhongchao Shanghai since August 2012. From January 2021 and September 2023, Mr. Yang served as the co-chief executive officer and director of TradeUp Acquisition Corp. (NASDAQ: UPTD), a special purpose acquisition corporation. From June 2013 to June 2016, Mr. Yang served as the first Chinese board member on the Global Alliance for Medical Education (GAME), a non-for-profit organization dedicated to the advancement of innovation in medical education throughout the world. From October 2010 to July 2012, Mr. Yang was the general manager at Medwork, a continuing medical education company. Mr. Yang a master's degree in business administration from the School of Economics and Management of Tsinghua University in 2024 and obtained a bachelor's degree in Clinical Medicine Science (traumatic surgery) from Gannan Medical University in 2005. Mr. Yang attended the master course of Social Medicine and Health Management as continuing education from 2006 to 2008 in Capital Medical University of China. From 2010 to 2012, Mr. Yang took part in the master course of Integrated Marketing Communication in Tsinghua University. - Weiguang Yang为Tradeup Acquisition Corp.的联席首席执行官兼董事。Yang先生目前担任Zhongchao Inc.总裁、董事长兼首席执行官，Zhongchao Inc.是一家在纳斯达克上市的公司（Nasdaq：ZCMD），他于2012年创立了Zhongchao Inc.。2013年6月至2016年6月，Yang先生担任全球医学教育联盟的首位中国董事会成员，该联盟是一个致力于推动世界各地医学教育创新的非营利组织。从2005年10月至2012年7月，Yang先生在医学继续教育公司Medwork担任总经理。Yang先生于2005年获得赣南医科大学临床医学科学（创伤外科）学士学位。2006年至2008年，Yang先生还参加了中国首都医科大学社会医学与健康管理硕士课程的继续教育。2010年至2012年，Yang先生在清华大学攻读整合营销传播硕士课程。
- Weiguang Yang,is the founder of Zhongchao Inc. and Zhongchao Shanghai. He has served as general manager Zhongchao Shanghai since August 2012. From January 2021 and September 2023, Mr. Yang served as the co-chief executive officer and director of TradeUp Acquisition Corp. (NASDAQ: UPTD), a special purpose acquisition corporation. From June 2013 to June 2016, Mr. Yang served as the first Chinese board member on the Global Alliance for Medical Education (GAME), a non-for-profit organization dedicated to the advancement of innovation in medical education throughout the world. From October 2010 to July 2012, Mr. Yang was the general manager at Medwork, a continuing medical education company. Mr. Yang a master's degree in business administration from the School of Economics and Management of Tsinghua University in 2024 and obtained a bachelor's degree in Clinical Medicine Science (traumatic surgery) from Gannan Medical University in 2005. Mr. Yang attended the master course of Social Medicine and Health Management as continuing education from 2006 to 2008 in Capital Medical University of China. From 2010 to 2012, Mr. Yang took part in the master course of Integrated Marketing Communication in Tsinghua University.
- Kevin Dean Vassily
-
Kevin Dean Vassily是公司的独立董事。 Vassily先生曾在Woodseer担任顾问，负责为金融技术公司提供战略和业务开发服务，从2019年3月至今提供全球股息预测。他是Go Capture的顾问，从2018年7月至今为新兴的“数据即服务”平台提供战略，业务开发和产品开发咨询工作。他还担任普罗米修斯基金的顾问，负责从2018年7月至今为专注于“绿色”经济的上海商行/私募股权公司提供战略，尽职调查和机会采购。 Vassily先生曾在Keybanc Capital Markets担任研究副总监，负责KeyBanc Data Insights计划，并于2015年1月至2018年6月共同管理垂直技术研究。从2010年12月至2014年12月，他担任研究总监。在Pacific Epoch，负责产品的全面检修和完整的业务模型，并在收购后重新开始，重点是“数据优先”产品。从2007年5月至2010年12月，他在Pacific Crest Securities担任亚洲技术业务开发/高级分析师，负责建立公司在亚洲技术领域的业务和相关性。从2003年6月至2006年9月，他担任Susquehanna International Group半导体技术小组的高级研究分析师，负责半导体和相关技术的研究。从2001年1月至2003年5月，他在Thomas Weisel Partners担任半导体资本设备副总裁兼高级研究分析师，负责发布研究报告并维护所研究的每家公司的财务模型。他拥有Denison大学的文科学士学位和Dartmouth College的塔克商学院的商业管理硕士学位。
Kevin Dean Vassily has served as director since Augt 2025. Mr. Vassily has served as an independent director of Zhongchao Inc. since February 2020, an independent director of Tungray Technologies Inc. (NASDAQ: TRSG) since March 2024, and an independent director of Autozi Internet Technology (Global) Ltd. (NASDAQ: AZI) since Augt 2024. Mr. Vassily is an independent director for two Nasdaq listed special purpose acquisition companies, including Denali Capital Acquisition Corp. (NASDAQ: DECA) since April 2022, and Aimfinity Investment Corp. I (NASDAQ: AIMA) since March 2023. From June 2022 until June 2024, Mr. Vassily served as an independent director of Feutune Light Acquisition Corp. (NASDAQ: FLFV), a special purpose acquisition company, when FLV completed its biness combination with Thunder Por Holdings Limited. Following the merger, he has served as an independent director of the combined entity, Thunder Por Holdings Inc. (NASDAQ: AIEV). Mr. Vassily served as Chief Financial Officer of iPor Inc. (NASDAQ: IPW) from January 2021 to May 2025 and as a member of its board of directors from March 2021 to May 2025. Earlier in his career, Mr. Vassily held vario advisory and research roles, including Vice President of Market Development at Facte from 2019 to January 2021, an advisor at Go Capture from July 2018 to January 2020, an associate director of research at Keybanc Capital Markets from January 2015 to June 2018, director of research at Pacific Epoch from December 2010 to December 2014, and senior analyst positions at Pacific Crest Securities, Squehanna International Group, and Thomas isel Partners. Mr. Vassily holds a bachelor's degree in liberal arts from Denison University and an MBA from the Tuck School of Biness at Dartmouth College. - Kevin Dean Vassily是公司的独立董事。 Vassily先生曾在Woodseer担任顾问，负责为金融技术公司提供战略和业务开发服务，从2019年3月至今提供全球股息预测。他是Go Capture的顾问，从2018年7月至今为新兴的“数据即服务”平台提供战略，业务开发和产品开发咨询工作。他还担任普罗米修斯基金的顾问，负责从2018年7月至今为专注于“绿色”经济的上海商行/私募股权公司提供战略，尽职调查和机会采购。 Vassily先生曾在Keybanc Capital Markets担任研究副总监，负责KeyBanc Data Insights计划，并于2015年1月至2018年6月共同管理垂直技术研究。从2010年12月至2014年12月，他担任研究总监。在Pacific Epoch，负责产品的全面检修和完整的业务模型，并在收购后重新开始，重点是“数据优先”产品。从2007年5月至2010年12月，他在Pacific Crest Securities担任亚洲技术业务开发/高级分析师，负责建立公司在亚洲技术领域的业务和相关性。从2003年6月至2006年9月，他担任Susquehanna International Group半导体技术小组的高级研究分析师，负责半导体和相关技术的研究。从2001年1月至2003年5月，他在Thomas Weisel Partners担任半导体资本设备副总裁兼高级研究分析师，负责发布研究报告并维护所研究的每家公司的财务模型。他拥有Denison大学的文科学士学位和Dartmouth College的塔克商学院的商业管理硕士学位。
- Kevin Dean Vassily has served as director since Augt 2025. Mr. Vassily has served as an independent director of Zhongchao Inc. since February 2020, an independent director of Tungray Technologies Inc. (NASDAQ: TRSG) since March 2024, and an independent director of Autozi Internet Technology (Global) Ltd. (NASDAQ: AZI) since Augt 2024. Mr. Vassily is an independent director for two Nasdaq listed special purpose acquisition companies, including Denali Capital Acquisition Corp. (NASDAQ: DECA) since April 2022, and Aimfinity Investment Corp. I (NASDAQ: AIMA) since March 2023. From June 2022 until June 2024, Mr. Vassily served as an independent director of Feutune Light Acquisition Corp. (NASDAQ: FLFV), a special purpose acquisition company, when FLV completed its biness combination with Thunder Por Holdings Limited. Following the merger, he has served as an independent director of the combined entity, Thunder Por Holdings Inc. (NASDAQ: AIEV). Mr. Vassily served as Chief Financial Officer of iPor Inc. (NASDAQ: IPW) from January 2021 to May 2025 and as a member of its board of directors from March 2021 to May 2025. Earlier in his career, Mr. Vassily held vario advisory and research roles, including Vice President of Market Development at Facte from 2019 to January 2021, an advisor at Go Capture from July 2018 to January 2020, an associate director of research at Keybanc Capital Markets from January 2015 to June 2018, director of research at Pacific Epoch from December 2010 to December 2014, and senior analyst positions at Pacific Crest Securities, Squehanna International Group, and Thomas isel Partners. Mr. Vassily holds a bachelor's degree in liberal arts from Denison University and an MBA from the Tuck School of Biness at Dartmouth College.
- 李丹
-
李丹是公司的独立董事。李女士现任中国首都医科大学附属北京友谊医院研究助理，自2012年6月至今负责热带疾病研究和病原微生物检测试剂盒的开发。 2009年10月至2011年11月，她担任EPS Corporation药品管理部门的经理，负责管理从日本进口到中国的药品。李女士拥有华北大学医学院临床医学学士学位。北京大学医学院血液流变学硕士学位和科学技术博士学位。庆应义University大学医学院生物化学专业博士。
Dan Li,is an independent director of the Company. Ms. Li works as the research assistant in Beijing Friendship Hospital - China Capital Medical University, responsible for conducting research in tropical diseases and development of detection kit of pathogenic microorganism from June 2012 to present. She served as a manager of the medicine management department in EPS Corporation, responsible for managing the importation of medicines from Japan to China from October 2009 to November 2011. Ms. Li holds a bachelor degree in clinical medicine from the Medical School of North China University of Science and Technology, a master degree in hemorheology from the Medical School of Peking University, and a Ph.D. in biochemistry from the Medical School of Keio University. - 李丹是公司的独立董事。李女士现任中国首都医科大学附属北京友谊医院研究助理，自2012年6月至今负责热带疾病研究和病原微生物检测试剂盒的开发。 2009年10月至2011年11月，她担任EPS Corporation药品管理部门的经理，负责管理从日本进口到中国的药品。李女士拥有华北大学医学院临床医学学士学位。北京大学医学院血液流变学硕士学位和科学技术博士学位。庆应义University大学医学院生物化学专业博士。
- Dan Li,is an independent director of the Company. Ms. Li works as the research assistant in Beijing Friendship Hospital - China Capital Medical University, responsible for conducting research in tropical diseases and development of detection kit of pathogenic microorganism from June 2012 to present. She served as a manager of the medicine management department in EPS Corporation, responsible for managing the importation of medicines from Japan to China from October 2009 to November 2011. Ms. Li holds a bachelor degree in clinical medicine from the Medical School of North China University of Science and Technology, a master degree in hemorheology from the Medical School of Peking University, and a Ph.D. in biochemistry from the Medical School of Keio University.
- John C. General
-
John C. General是公司的独立董事。 General先生担任Avaya全球收入保证高级经理，负责根据现行会计准则适当确认收入，并自2013年4月至今审核交易以进行审计。他曾在Value Services Inc.的Bed Bath＆Beyond担任财务运营经理，从2010年7月至2013年4月负责公司礼品卡业务所有零售概念的控制权和合规报告。 2004年7月至2009年3月，负责维珍移动公司SOX实施部门，负责确保SOX的合规性。从1986年9月至2003年12月，他在AT＆T Corp.担任过多个职位，最后一次担任财务总监，负责收入保证和计费操作。他拥有注册会计师执照，哥伦比亚大学的高级管理人员教育证书，罗格斯大学的金融MBA学位以及费尔利·狄金森大学的经济学和会计学学士学位。
John C. General,is an independent director of the Company. Mr. General serves as the Vice President of Revenue Accounting for Moody's Corporation where he is responsible for the technical analysis of transactions and the assurance of the proper recognition and recording of transactions relating to revenue recognition. He served as an advisor to Workday and Google regarding revenue recognition for complex contract arrangements. He served as Senior Manager of Global Revenue Assurance for Avaya, responsible for the appropriate recognition of revenue under current accounting standards, and review of transactions for audit purposes from April 2013 to June 2020. He served as a manager of financial operations for Bed Bath & Beyond, Value Services Inc., responsible for the controllership and compliance reporting for the Company's gift card business for all retail concepts from July 2010 to April 2013. He served as a director in the department of SOX Implementation for Virgin Mobile, responsible for ensuring SOX compliance from July 2004 to March 2009. From September 1986 to December 2003, he served in various positions at AT&T Corp., where he last served as a Financial Director responsible for revenue assurance and billing operations. He holds a license as a Certified Public Accountant, a certificate in Senior Executive Education from Columbia University, an MBA in Finance from Rutgers University, and bachelor's degrees in both economics and accounting from Fairleigh Dickinson University. - John C. General是公司的独立董事。 General先生担任Avaya全球收入保证高级经理，负责根据现行会计准则适当确认收入，并自2013年4月至今审核交易以进行审计。他曾在Value Services Inc.的Bed Bath＆Beyond担任财务运营经理，从2010年7月至2013年4月负责公司礼品卡业务所有零售概念的控制权和合规报告。 2004年7月至2009年3月，负责维珍移动公司SOX实施部门，负责确保SOX的合规性。从1986年9月至2003年12月，他在AT＆T Corp.担任过多个职位，最后一次担任财务总监，负责收入保证和计费操作。他拥有注册会计师执照，哥伦比亚大学的高级管理人员教育证书，罗格斯大学的金融MBA学位以及费尔利·狄金森大学的经济学和会计学学士学位。
- John C. General,is an independent director of the Company. Mr. General serves as the Vice President of Revenue Accounting for Moody's Corporation where he is responsible for the technical analysis of transactions and the assurance of the proper recognition and recording of transactions relating to revenue recognition. He served as an advisor to Workday and Google regarding revenue recognition for complex contract arrangements. He served as Senior Manager of Global Revenue Assurance for Avaya, responsible for the appropriate recognition of revenue under current accounting standards, and review of transactions for audit purposes from April 2013 to June 2020. He served as a manager of financial operations for Bed Bath & Beyond, Value Services Inc., responsible for the controllership and compliance reporting for the Company's gift card business for all retail concepts from July 2010 to April 2013. He served as a director in the department of SOX Implementation for Virgin Mobile, responsible for ensuring SOX compliance from July 2004 to March 2009. From September 1986 to December 2003, he served in various positions at AT&T Corp., where he last served as a Financial Director responsible for revenue assurance and billing operations. He holds a license as a Certified Public Accountant, a certificate in Senior Executive Education from Columbia University, an MBA in Finance from Rutgers University, and bachelor's degrees in both economics and accounting from Fairleigh Dickinson University.
- 徐珮
-
徐珮，女，中国国籍，无境外永久居留权，1982年8月出生，本科学历，收盘后成为Estrella董事会成员。徐女士是众巢医学有限公司（纳斯达克：ZCMD）的首席财务官，该公司是一家为中国医疗保健专业人士和公众提供医疗保健信息、教育和培训服务的提供商。徐女士还自2016年1月起担任众巢医学有限公司的中国关联公司众巢医学科技（上海）有限公司（“众巢上海”）的首席财务官。2013年9月至2016年1月，徐女士担任中超上海的财务总监。2008年9月至2013年8月，徐女士任职于大冢（中国）投资有限公司，担任财务总监；2013年9月至2016年1月，就职于众巢有限，任财务总监。徐女士拥有江西财经大学金融学学士学位。
Pei Xu is the CFO of Zhongchao Inc. (Nasdaq: ZCMD), a provider of healthcare information, education, and training services to healthcare professionals and the public in China. Ms. Xu has also served as the CFO of Zhongchao Medical Technology (Shanghai) Co., Ltd. ("Zhongchao Shanghai"), Zhongchao Inc.'s Chinese affiliate, since January 2016. From September 2013 to January 2016, Ms. Xu served as the financial director of Zhongchao Shanghai. From September 2008 to Augt 2013, Ms. Xu worked for Otsuka (China) Investment Co., Ltd. as a financial director. Ms. Xu holds a bachelor degree in finance from Jiangxi University of Finance and Economics. - 徐珮，女，中国国籍，无境外永久居留权，1982年8月出生，本科学历，收盘后成为Estrella董事会成员。徐女士是众巢医学有限公司（纳斯达克：ZCMD）的首席财务官，该公司是一家为中国医疗保健专业人士和公众提供医疗保健信息、教育和培训服务的提供商。徐女士还自2016年1月起担任众巢医学有限公司的中国关联公司众巢医学科技（上海）有限公司（“众巢上海”）的首席财务官。2013年9月至2016年1月，徐女士担任中超上海的财务总监。2008年9月至2013年8月，徐女士任职于大冢（中国）投资有限公司，担任财务总监；2013年9月至2016年1月，就职于众巢有限，任财务总监。徐女士拥有江西财经大学金融学学士学位。
- Pei Xu is the CFO of Zhongchao Inc. (Nasdaq: ZCMD), a provider of healthcare information, education, and training services to healthcare professionals and the public in China. Ms. Xu has also served as the CFO of Zhongchao Medical Technology (Shanghai) Co., Ltd. ("Zhongchao Shanghai"), Zhongchao Inc.'s Chinese affiliate, since January 2016. From September 2013 to January 2016, Ms. Xu served as the financial director of Zhongchao Shanghai. From September 2008 to Augt 2013, Ms. Xu worked for Otsuka (China) Investment Co., Ltd. as a financial director. Ms. Xu holds a bachelor degree in finance from Jiangxi University of Finance and Economics.
高管简历
中英对照 | 中文 | 英文- Weiguang Yang
Weiguang Yang为Tradeup Acquisition Corp.的联席首席执行官兼董事。Yang先生目前担任Zhongchao Inc.总裁、董事长兼首席执行官，Zhongchao Inc.是一家在纳斯达克上市的公司（Nasdaq：ZCMD），他于2012年创立了Zhongchao Inc.。2013年6月至2016年6月，Yang先生担任全球医学教育联盟的首位中国董事会成员，该联盟是一个致力于推动世界各地医学教育创新的非营利组织。从2005年10月至2012年7月，Yang先生在医学继续教育公司Medwork担任总经理。Yang先生于2005年获得赣南医科大学临床医学科学（创伤外科）学士学位。2006年至2008年，Yang先生还参加了中国首都医科大学社会医学与健康管理硕士课程的继续教育。2010年至2012年，Yang先生在清华大学攻读整合营销传播硕士课程。
Weiguang Yang,is the founder of Zhongchao Inc. and Zhongchao Shanghai. He has served as general manager Zhongchao Shanghai since August 2012. From January 2021 and September 2023, Mr. Yang served as the co-chief executive officer and director of TradeUp Acquisition Corp. (NASDAQ: UPTD), a special purpose acquisition corporation. From June 2013 to June 2016, Mr. Yang served as the first Chinese board member on the Global Alliance for Medical Education (GAME), a non-for-profit organization dedicated to the advancement of innovation in medical education throughout the world. From October 2010 to July 2012, Mr. Yang was the general manager at Medwork, a continuing medical education company. Mr. Yang a master's degree in business administration from the School of Economics and Management of Tsinghua University in 2024 and obtained a bachelor's degree in Clinical Medicine Science (traumatic surgery) from Gannan Medical University in 2005. Mr. Yang attended the master course of Social Medicine and Health Management as continuing education from 2006 to 2008 in Capital Medical University of China. From 2010 to 2012, Mr. Yang took part in the master course of Integrated Marketing Communication in Tsinghua University.- Weiguang Yang为Tradeup Acquisition Corp.的联席首席执行官兼董事。Yang先生目前担任Zhongchao Inc.总裁、董事长兼首席执行官，Zhongchao Inc.是一家在纳斯达克上市的公司（Nasdaq：ZCMD），他于2012年创立了Zhongchao Inc.。2013年6月至2016年6月，Yang先生担任全球医学教育联盟的首位中国董事会成员，该联盟是一个致力于推动世界各地医学教育创新的非营利组织。从2005年10月至2012年7月，Yang先生在医学继续教育公司Medwork担任总经理。Yang先生于2005年获得赣南医科大学临床医学科学（创伤外科）学士学位。2006年至2008年，Yang先生还参加了中国首都医科大学社会医学与健康管理硕士课程的继续教育。2010年至2012年，Yang先生在清华大学攻读整合营销传播硕士课程。
- Weiguang Yang,is the founder of Zhongchao Inc. and Zhongchao Shanghai. He has served as general manager Zhongchao Shanghai since August 2012. From January 2021 and September 2023, Mr. Yang served as the co-chief executive officer and director of TradeUp Acquisition Corp. (NASDAQ: UPTD), a special purpose acquisition corporation. From June 2013 to June 2016, Mr. Yang served as the first Chinese board member on the Global Alliance for Medical Education (GAME), a non-for-profit organization dedicated to the advancement of innovation in medical education throughout the world. From October 2010 to July 2012, Mr. Yang was the general manager at Medwork, a continuing medical education company. Mr. Yang a master's degree in business administration from the School of Economics and Management of Tsinghua University in 2024 and obtained a bachelor's degree in Clinical Medicine Science (traumatic surgery) from Gannan Medical University in 2005. Mr. Yang attended the master course of Social Medicine and Health Management as continuing education from 2006 to 2008 in Capital Medical University of China. From 2010 to 2012, Mr. Yang took part in the master course of Integrated Marketing Communication in Tsinghua University.
- 陈学军
陈学军，Zhongchao Inc.首席医官，Zhongchao Shanghai医药部副总经理。2012年3月起任Zhongchao Shanghai医药副总经理，主要负责Zhongchao Inc. PI和COPS课程的设计。MDMOOC在线平台。2010年1月至2012年2月，他还担任Medwork的医疗总监。从2008年9月到2009年12月，他担任D&S（一家中国公关公司）的医疗总监。他持有山西医科大学临床医学学士学位和哈尔滨商业大学药理学硕士学位。
Xuejun Chen,is the Chief Medical Officer of Zhongchao Inc. and Deputy General Manager of Medicine of Zhongchao Shanghai. He has been serving as Zhongchao Inc. deputy general manager of medicine of Zhongchao Shanghai since March 2012, mainly responsible for designing PI and COPS courses on Zhongchao Inc. MDMOOC online platform. Mr. Chen also serves as medical Director at Medwork from January 2010 to February 2012. From September 2008 to December 2009, Mr. Chen served D&S, a Chinese public relation corporation, as medical director. Mr. Chen holds a bachelor degree in Clinical Medicine Science from Shanxi Medical University and a master degree in pharmacology from Harbin University of Commerce.- 陈学军，Zhongchao Inc.首席医官，Zhongchao Shanghai医药部副总经理。2012年3月起任Zhongchao Shanghai医药副总经理，主要负责Zhongchao Inc. PI和COPS课程的设计。MDMOOC在线平台。2010年1月至2012年2月，他还担任Medwork的医疗总监。从2008年9月到2009年12月，他担任D&S（一家中国公关公司）的医疗总监。他持有山西医科大学临床医学学士学位和哈尔滨商业大学药理学硕士学位。
- Xuejun Chen,is the Chief Medical Officer of Zhongchao Inc. and Deputy General Manager of Medicine of Zhongchao Shanghai. He has been serving as Zhongchao Inc. deputy general manager of medicine of Zhongchao Shanghai since March 2012, mainly responsible for designing PI and COPS courses on Zhongchao Inc. MDMOOC online platform. Mr. Chen also serves as medical Director at Medwork from January 2010 to February 2012. From September 2008 to December 2009, Mr. Chen served D&S, a Chinese public relation corporation, as medical director. Mr. Chen holds a bachelor degree in Clinical Medicine Science from Shanxi Medical University and a master degree in pharmacology from Harbin University of Commerce.
- 田宝乾
田宝乾，一直担任Zhongchao Inc.董事。Zhongchao Inc.首席销售官，Zhongchao Shanghai销售副总经理。他自2017年11月起担任Zhongchao Inc. Zhongchao Shanghai的销售副总经理。加入Zhongchao Inc.之前，2010年7月至2016年7月，他担任Beijing Think Marketing Consulting Co.，Ltd.的客户总监，Beijing Think Marketing Consulting Co.，Ltd.是制药企业的广告和咨询服务提供商。从2007年7月到2010年7月，他担任China International Exhibition Center Group Corporation的项目经理。他持有北京第二外国语大学旅游管理（活动管理）学士学位和中国科学院大学工商管理硕士学位。
Baoqian Tian,has been serving as Chief Sales Officer of Zhongchao Inc. and Deputy General Manager of Sales of Zhongchao Shanghai. He has been serving as deputy general manager of sales of Zhongchao Shanghai since November 2017. Prior to joining Zhongchao Inc. , he served as the account director in Beijing Think Marketing Consulting Co., Ltd., a provider of advertising and consulting services to pharmaceutical enterprises from July 2010 to July 2016. From July 2007 to July 2010, Mr. Tian worked as a project manager of China International Exhibition Center Group Corporation. Mr. Tian holds a bachelor degree in Tourism Management (Event Management) from Beijing International Studies University and a master degree in Business Administration from University of Chinese Academy of Sciences.- 田宝乾，一直担任Zhongchao Inc.董事。Zhongchao Inc.首席销售官，Zhongchao Shanghai销售副总经理。他自2017年11月起担任Zhongchao Inc. Zhongchao Shanghai的销售副总经理。加入Zhongchao Inc.之前，2010年7月至2016年7月，他担任Beijing Think Marketing Consulting Co.，Ltd.的客户总监，Beijing Think Marketing Consulting Co.，Ltd.是制药企业的广告和咨询服务提供商。从2007年7月到2010年7月，他担任China International Exhibition Center Group Corporation的项目经理。他持有北京第二外国语大学旅游管理（活动管理）学士学位和中国科学院大学工商管理硕士学位。
- Baoqian Tian,has been serving as Chief Sales Officer of Zhongchao Inc. and Deputy General Manager of Sales of Zhongchao Shanghai. He has been serving as deputy general manager of sales of Zhongchao Shanghai since November 2017. Prior to joining Zhongchao Inc. , he served as the account director in Beijing Think Marketing Consulting Co., Ltd., a provider of advertising and consulting services to pharmaceutical enterprises from July 2010 to July 2016. From July 2007 to July 2010, Mr. Tian worked as a project manager of China International Exhibition Center Group Corporation. Mr. Tian holds a bachelor degree in Tourism Management (Event Management) from Beijing International Studies University and a master degree in Business Administration from University of Chinese Academy of Sciences.
- 吴爽
吴爽，是Zhongchao Inc.和Zhongchao Shanghai的首席运营官。她一直担任Zhongchao Inc.的董事。自2012年3月起担任Zhongchao Shanghai首席运营官。她也是阳光健康论坛的创始人。她持有华北科技大学医疗保健管理学士学位。
Shuang Wu,is the Chief Operating Officer of Zhongchao Inc. and Zhongchao Shanghai. She has been serving as Chief Operating Officer of Zhongchao Shanghai since March 2012. She is also the founder of Sunshine Health Forum. Ms. Wu holds a Bachelor of Management in healthcare management from North China University of Science and Technology.- 吴爽，是Zhongchao Inc.和Zhongchao Shanghai的首席运营官。她一直担任Zhongchao Inc.的董事。自2012年3月起担任Zhongchao Shanghai首席运营官。她也是阳光健康论坛的创始人。她持有华北科技大学医疗保健管理学士学位。
- Shuang Wu,is the Chief Operating Officer of Zhongchao Inc. and Zhongchao Shanghai. She has been serving as Chief Operating Officer of Zhongchao Shanghai since March 2012. She is also the founder of Sunshine Health Forum. Ms. Wu holds a Bachelor of Management in healthcare management from North China University of Science and Technology.
- 徐珮
徐珮，女，中国国籍，无境外永久居留权，1982年8月出生，本科学历，收盘后成为Estrella董事会成员。徐女士是众巢医学有限公司（纳斯达克：ZCMD）的首席财务官，该公司是一家为中国医疗保健专业人士和公众提供医疗保健信息、教育和培训服务的提供商。徐女士还自2016年1月起担任众巢医学有限公司的中国关联公司众巢医学科技（上海）有限公司（“众巢上海”）的首席财务官。2013年9月至2016年1月，徐女士担任中超上海的财务总监。2008年9月至2013年8月，徐女士任职于大冢（中国）投资有限公司，担任财务总监；2013年9月至2016年1月，就职于众巢有限，任财务总监。徐女士拥有江西财经大学金融学学士学位。
Pei Xu is the CFO of Zhongchao Inc. (Nasdaq: ZCMD), a provider of healthcare information, education, and training services to healthcare professionals and the public in China. Ms. Xu has also served as the CFO of Zhongchao Medical Technology (Shanghai) Co., Ltd. ("Zhongchao Shanghai"), Zhongchao Inc.'s Chinese affiliate, since January 2016. From September 2013 to January 2016, Ms. Xu served as the financial director of Zhongchao Shanghai. From September 2008 to Augt 2013, Ms. Xu worked for Otsuka (China) Investment Co., Ltd. as a financial director. Ms. Xu holds a bachelor degree in finance from Jiangxi University of Finance and Economics.- 徐珮，女，中国国籍，无境外永久居留权，1982年8月出生，本科学历，收盘后成为Estrella董事会成员。徐女士是众巢医学有限公司（纳斯达克：ZCMD）的首席财务官，该公司是一家为中国医疗保健专业人士和公众提供医疗保健信息、教育和培训服务的提供商。徐女士还自2016年1月起担任众巢医学有限公司的中国关联公司众巢医学科技（上海）有限公司（“众巢上海”）的首席财务官。2013年9月至2016年1月，徐女士担任中超上海的财务总监。2008年9月至2013年8月，徐女士任职于大冢（中国）投资有限公司，担任财务总监；2013年9月至2016年1月，就职于众巢有限，任财务总监。徐女士拥有江西财经大学金融学学士学位。
- Pei Xu is the CFO of Zhongchao Inc. (Nasdaq: ZCMD), a provider of healthcare information, education, and training services to healthcare professionals and the public in China. Ms. Xu has also served as the CFO of Zhongchao Medical Technology (Shanghai) Co., Ltd. ("Zhongchao Shanghai"), Zhongchao Inc.'s Chinese affiliate, since January 2016. From September 2013 to January 2016, Ms. Xu served as the financial director of Zhongchao Shanghai. From September 2008 to Augt 2013, Ms. Xu worked for Otsuka (China) Investment Co., Ltd. as a financial director. Ms. Xu holds a bachelor degree in finance from Jiangxi University of Finance and Economics.